Merck CEO Who Developed Ebola Vaccine Talks Covid-19

(Bloomberg) -- For nearly six months, U.S. drug giant Merck & Co. led a quiet effort to reach deals and secure federal funding to develop vaccines against the deadly coronavirus.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.